P15-20. Developing a national policy agenda for the Canadian HIV vaccine initiative
Bibliographic record
Abstract
The Canadian HIV Vaccine Initiative (CHVI) is a five-year initiative between the Government of Canada and the Bill & Melinda Gates Foundation, and it represents a significant Canadian contribution to the Global HIV Vaccine Enterprise that seeks to accelerate the development of safe, effective, affordable and globally accessible HIV vaccines. A national HIV vaccines policy agenda is currently being developed as one measure to contribute to domestic and international HIV vaccines policy-related efforts. To ensure alignment with global HIV vaccines efforts, a consultation process with international experts was undertaken in fall 2008 – winter 2009 to seek input on key policy issues and potential areas of focus for a Canadian HIV vaccines policy agenda. The consultations identified several key policy issues that need to be resolved domestically and globally on the policy front. These include: focussing on the science to develop an effective vaccine; assist low- and middle-income countries in developing regulatory systems and processes to enable approval and implementation of clinical trials, and; positioning HIV vaccines as part of a comprehensive prevention approach. The consultations also identified areas of focus for the CHVI policy agenda: share Canada's unique approach to HIV prevention; initiate and supporting ongoing global policy dialogue; engage global partners to raise profile of HIV/AIDS issues, and; provide support to global approaches to address regulatory barriers in HIV vaccine development and delivery. The consultation process was very valuable in identifying current global policy issues and proposed areas for inclusion in a CHVI Policy Agenda. The consultations also demonstrated the interest and support for a more formalized global policy network under the leadership of the Global HIV Vaccine Enterprise. Canada is well positioned to develop a sound policy agenda, one that will contribute to both domestic and global goals to advance the development of an HIV vaccine.
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.016 | 0.022 |
| Meta-epidemiology (narrow) | 0.001 | 0.001 |
| Meta-epidemiology (broad) | 0.001 | 0.002 |
| Bibliometrics | 0.002 | 0.002 |
| Science and technology studies | 0.024 | 0.006 |
| Scholarly communication | 0.021 | 0.007 |
| Open science | 0.004 | 0.007 |
| Research integrity | 0.026 | 0.018 |
| Insufficient payload (model declined to judge) | 0.050 | 0.009 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".